Archived - Important Safety Information Regarding Early Virologic Non-response in Patients with HIV Infection Treated with 3TC® (lamivudine), Ziagen® (abacavir) and VireadTM (tenofovir) - GlaxoSmithKline Inc.
Issued October 17, 2003
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker